Synopsis
Synopsis
0
VMF
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
1. 5-(2-((2-(2-ethoxyphenoxy)ethyl)amino)propyl)-2-methoxybenzenesulfonamide
2. Flomax
3. Ly 253352
4. Ly-253352
5. Tamsulosin
6. Ym 617
7. Ym-617
1. 106463-17-6
2. Flomax
3. Tamsulosin Hcl
4. Omnic
5. Pradif
6. Harnal
7. Urolosin
8. Secotex
9. Josir
10. Alna
11. Omic
12. Omix
13. Ym617
14. Ly253351
15. Amsulosin Hydrochloride
16. Tamsulosin (hydrochloride)
17. (r)-5-(2-((2-(2-ethoxyphenoxy)ethyl)amino)propyl)-2-methoxybenzenesulfonamide Hydrochloride
18. R-(-)-ym-12617
19. Ym 617
20. Ym-12617-1
21. Ym-617
22. Ly-253351
23. Chebi:9399
24. (-)-(r)-5-(2-((2-(o-ethoxyphenoxy)ethyl)amino)propyl)-2-methoxybenzenesulfonamide Monohydrochloride
25. 11sv1951mr
26. 5-[(2r)-2-[[2-(2-ethoxyphenoxy)ethyl]amino]propyl]-2-methoxybenzenesulfonamide Hydrochloride
27. 5-[(2r)-2-[2-(2-ethoxyphenoxy)ethylamino]propyl]-2-methoxybenzenesulfonamide;hydrochloride
28. 5-[(r)-2-[2-(2-ethoxyphenoxy)ethylamino]propyl]]-2-methoxybenzenesulfonamide Hydrochloride
29. R-(-)-5-(2-((2-(2-ethoxyphenoxy)ethyl)amino)propyl)-2-methoxybenzenesulfonamide Hydrochloride
30. Expros
31. Flomax (tn)
32. Dsstox_cid_26628
33. Dsstox_rid_81777
34. Dsstox_gsid_46628
35. 128332-25-2
36. Benzenesulfonamide, 5-(2-((2-(2-ethoxyphenoxy)ethyl)amino)propyl)-2-methoxy-, Monohydrochloride, (r)-
37. (r)-5-(2-(2-(2-ethoxyphenoxy)ethylamino)propyl)-2-methoxybenzenesulfonamide Hydrochloride
38. (-)-(r)-5-(2-((2-(o-ethoxyphenoxy)ethyl)amino)propyl)-2-methoxybenzene Sulfonamide Monohydrochloride
39. Cas-106463-17-6
40. Tamsulosine Hydrochloride
41. Ncgc00167442-01
42. Mfcd00922997
43. (r)-tamsulosin Hydrochloride
44. Unii-11sv1951mr
45. Tamsulosin.hcl
46. Harnalidge Ocas
47. Flomax Mr
48. Alnaocas
49. 5-[(2r)-2-{[2-(2-ethoxyphenoxy)ethyl]amino}propyl]-2-methoxybenzenesulfonamide Hydrochloride
50. Flomax Hydrochloride
51. Harnal (tn)
52. Tamsulosin Hydrochloride [usan:usp:jan]
53. Tamsulosina Hydrochloride
54. Tamsulosinum Hydrochloride
55. (-)-ly 253352
56. Schembl23428
57. Tamsulosin Hydrochloride,(s)
58. Mls003899197
59. Racemic Tamsulosin Hydrochloride
60. Chembl1200914
61. Dtxsid2046628
62. Hy-b0661a
63. 5-[(2rs)-2-[[2-(2-ethoxyphenoxy)ethyl]amino]propyl]-2-methoxybenzenesulfonamide Hydrochloride (tamsulosin Racemate Hydrochloride)
64. Tox21_112446
65. Eu-617
66. S4729
67. (r)-tamsulosin Hydrochloride- Bio-x
68. Tamsulosin Hydrochloride (jp17/usp)
69. Tamsulosin Hydrochloride [jan]
70. Akos015895342
71. Akos015995287
72. Tox21_112446_1
73. Bs-1019
74. Ccg-269178
75. Tamsulosin Hydrochloride [usan]
76. (-)-ly253352
77. Tamsulosin Hydrochloride [mart.]
78. Tamsulosin Hydrochloride [vandf]
79. Ncgc00167442-03
80. Tamsulosin Hydrochloride [usp-rs]
81. Tamsulosin Hydrochloride [who-dd]
82. Bt164440
83. Smr002543366
84. Bcp0726000042
85. Tamsulosin Hydrochloride, >=98% (hplc)
86. T2749
87. Y-617
88. Tamsulosin Hydrochloride [orange Book]
89. A14936
90. D01024
91. Jalyn Component Tamsulosin Hydrochloride
92. Tamsulosin Hydrochloride [ep Monograph]
93. Tamsulosin Hydrochloride [usp Impurity]
94. Tamsulosin Hydrochloride [usp Monograph]
95. 463t176
96. A801444
97. Tamsulosin Hydrochloride Component Of Jalyn
98. Q-201777
99. (r)-(-)-ym12617;ly253351
100. (r)-5-(2-(2-(2-ethoxyphenoxy)ethylamino)propyl)-2
101. Q27108379
102. Tamsulosin Hydrochloride, British Pharmacopoeia (bp) Reference Standard
103. Tamsulosin Hydrochloride, European Pharmacopoeia (ep) Reference Standard
104. (r)-5-(2-((2-(2-ethoxyphenoxy)ethyl)amino)propyl)-2-methoxybenzenesulfonamide Hcl
105. 5-((2r)-2-(2-(2-ethoxyphenoxy)ethylamino)propyl)-2-methoxybenzene-sulfonamide Hcl
106. 5-[(r)-2-[2-(2-ethoxyphenoxy)ethylamino]propyl]]-2-methoxybenzenesulfonamidehydrochloride
107. Tamsulosin Hydrochloride, Pharmaceutical Secondary Standard; Certified Reference Material
108. Tamsulosin Hydrochloride, United States Pharmacopeia (usp) Reference Standard
109. (r)-5-(2-((2-(2-ethoxyphenoxy)ethyl)amino)propyl)-2-methoxybenzenesulfonamide Monohydrochloride
110. 5-[(2r)-2-[[2-(-ethoxyphenoxy)ethyl]amino]propyl]-2-methoxybenzenesulfonamide Hydrochloride;tamsulosin Hcl
Molecular Weight | 445.0 g/mol |
---|---|
Molecular Formula | C20H29ClN2O5S |
Hydrogen Bond Donor Count | 3 |
Hydrogen Bond Acceptor Count | 7 |
Rotatable Bond Count | 11 |
Exact Mass | 444.1485709 g/mol |
Monoisotopic Mass | 444.1485709 g/mol |
Topological Polar Surface Area | 108 Ų |
Heavy Atom Count | 29 |
Formal Charge | 0 |
Complexity | 539 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 1 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 2 |
1 of 4 | |
---|---|
Drug Name | Flomax |
PubMed Health | Tamsulosin (By mouth) |
Drug Classes | Benign Prostatic Hypertrophy Agent |
Drug Label | Tamsulosin hydrochloride is an antagonist of alpha1A adrenoceptors in the prostate.Tamsulosin hydrochloride is (-)-(R)-5-[2-[[2-(o-Ethoxyphenoxy) ethyl]amino]propyl]-2-methoxybenzenesulfonamide, monohydrochloride. Tamsulosin hydrochloride is a white... |
Active Ingredient | Tamsulosin hydrochloride |
Dosage Form | Capsule |
Route | Oral |
Strength | 0.4mg |
Market Status | Prescription |
Company | Boehringer Ingelheim |
2 of 4 | |
---|---|
Drug Name | Tamsulosin hydrochloride |
Drug Label | Tamsulosin hydrochloride is an antagonist of alpha1A adrenoceptors in the prostate.Tamsulosin hydrochloride is (-)-(R)-5-[2-[[2-(o-Ethoxyphenoxy) ethyl]amino]propyl]-2-methoxybenzenesulfonamide, monohydrochloride. Tamsulosin hydrochloride is a white... |
Active Ingredient | Tamsulosin hydrochloride |
Dosage Form | Capsule |
Route | oral; Oral |
Strength | 0.4mg |
Market Status | Tentative Approval; Prescription |
Company | Synthon Pharms; Anchen Pharms; Wockhardt; Ranbaxy; Aurobindo Pharma; Sun Pharm Inds; Sandoz; Teva Pharms; Zydus Pharms Usa; Mylan; Impax Labs |
3 of 4 | |
---|---|
Drug Name | Flomax |
PubMed Health | Tamsulosin (By mouth) |
Drug Classes | Benign Prostatic Hypertrophy Agent |
Drug Label | Tamsulosin hydrochloride is an antagonist of alpha1A adrenoceptors in the prostate.Tamsulosin hydrochloride is (-)-(R)-5-[2-[[2-(o-Ethoxyphenoxy) ethyl]amino]propyl]-2-methoxybenzenesulfonamide, monohydrochloride. Tamsulosin hydrochloride is a white... |
Active Ingredient | Tamsulosin hydrochloride |
Dosage Form | Capsule |
Route | Oral |
Strength | 0.4mg |
Market Status | Prescription |
Company | Boehringer Ingelheim |
4 of 4 | |
---|---|
Drug Name | Tamsulosin hydrochloride |
Drug Label | Tamsulosin hydrochloride is an antagonist of alpha1A adrenoceptors in the prostate.Tamsulosin hydrochloride is (-)-(R)-5-[2-[[2-(o-Ethoxyphenoxy) ethyl]amino]propyl]-2-methoxybenzenesulfonamide, monohydrochloride. Tamsulosin hydrochloride is a white... |
Active Ingredient | Tamsulosin hydrochloride |
Dosage Form | Capsule |
Route | oral; Oral |
Strength | 0.4mg |
Market Status | Tentative Approval; Prescription |
Company | Synthon Pharms; Anchen Pharms; Wockhardt; Ranbaxy; Aurobindo Pharma; Sun Pharm Inds; Sandoz; Teva Pharms; Zydus Pharms Usa; Mylan; Impax Labs |
Urological Agents
Drugs used in the treatment of urological conditions and diseases such as URINARY INCONTINENCE and URINARY TRACT INFECTIONS. (See all compounds classified as Urological Agents.)
Adrenergic alpha-1 Receptor Antagonists
Drugs that bind to and block the activation of ADRENERGIC ALPHA-1 RECEPTORS. (See all compounds classified as Adrenergic alpha-1 Receptor Antagonists.)
Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.
GDUFA
DMF Review : Complete
Rev. Date : 2015-12-23
Pay. Date : 2015-08-27
DMF Number : 28648
Submission : 2014-09-15
Status : Active
Type : II
Medichem is a vertically integrated pharmaceutical company specializing in the development & manufacturing of APIs & FDFs.
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 23145
Submission : 2009-09-30
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 13878
Submission : 1998-12-03
Status : Inactive
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 11761
Submission : 1995-12-01
Status : Inactive
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 18179
Submission : 2005-03-11
Status : Inactive
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 17318
Submission : 2004-04-09
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 17865
Submission : 2004-12-06
Status : Inactive
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 18067
Submission : 2005-01-22
Status : Inactive
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 18186
Submission : 2005-03-14
Status : Inactive
Type : II
GDUFA
DMF Review : Complete
Rev. Date : 2014-04-04
Pay. Date : 2014-03-27
DMF Number : 17688
Submission : 2004-09-17
Status : Active
Type : II
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
RLD : Yes
TE Code : AB
Brand Name : FLOMAX
Dosage Form : CAPSULE;ORAL
Dosage Strength : 0.4MG
Approval Date : 1997-04-15
Application Number : 20579
RX/OTC/DISCN : RX
RLD : Yes
TE Code : AB
RLD : No
TE Code :
DUTASTERIDE; TAMSULOSIN HYDROCHLORIDE
Brand Name : DUTASTERIDE AND TAMSULOSIN HYDROCHLORIDE
Dosage Form : CAPSULE;ORAL
Dosage Strength : 0.5MG;0.4MG
Approval Date : 2015-11-20
Application Number : 202975
RX/OTC/DISCN : DISCN
RLD : No
TE Code :
RLD : No
TE Code : AB
Brand Name : TAMSULOSIN HYDROCHLORIDE
Dosage Form : CAPSULE;ORAL
Dosage Strength : 0.4MG
Approval Date : 2017-08-11
Application Number : 207405
RX/OTC/DISCN : RX
RLD : No
TE Code : AB
RLD : No
TE Code : AB
Brand Name : TAMSULOSIN HYDROCHLORIDE
Dosage Form : CAPSULE;ORAL
Dosage Strength : 0.4MG
Approval Date : 2010-03-02
Application Number : 90377
RX/OTC/DISCN : RX
RLD : No
TE Code : AB
RLD : No
TE Code : AB
Brand Name : TAMSULOSIN HYDROCHLORIDE
Dosage Form : CAPSULE;ORAL
Dosage Strength : 0.4MG
Approval Date : 2017-01-20
Application Number : 204645
RX/OTC/DISCN : RX
RLD : No
TE Code : AB
RLD : No
TE Code : AB
Brand Name : TAMSULOSIN HYDROCHLORIDE
Dosage Form : CAPSULE;ORAL
Dosage Strength : 0.4MG
Approval Date : 2010-04-27
Application Number : 78801
RX/OTC/DISCN : RX
RLD : No
TE Code : AB
RLD : No
TE Code : AB
Brand Name : TAMSULOSIN HYDROCHLORIDE
Dosage Form : CAPSULE;ORAL
Dosage Strength : 0.4MG
Approval Date : 2010-04-27
Application Number : 78938
RX/OTC/DISCN : RX
RLD : No
TE Code : AB
RLD : No
TE Code : AB
Brand Name : TAMSULOSIN HYDROCHLORIDE
Dosage Form : CAPSULE;ORAL
Dosage Strength : 0.4MG
Approval Date : 2010-04-27
Application Number : 78225
RX/OTC/DISCN : RX
RLD : No
TE Code : AB
RLD : No
TE Code : AB
DUTASTERIDE; TAMSULOSIN HYDROCHLORIDE
Brand Name : DUTASTERIDE AND TAMSULOSIN HYDROCHLORIDE
Dosage Form : CAPSULE;ORAL
Dosage Strength : 0.5MG;0.4MG
Approval Date : 2018-05-24
Application Number : 207769
RX/OTC/DISCN : RX
RLD : No
TE Code : AB
Brand Name : TAMSULOSIN HYDROCHLORIDE
Dosage Form : CAPSULE;ORAL
Dosage Strength : 0.4MG
Approval Date : 2010-04-27
Application Number : 90408
RX/OTC/DISCN : DISCN
RLD : No
TE Code :
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Regulatory Info :
Registration Country : Switzerland
Dutasteride; Tamsulosin hydrochloride
Brand Name : Dutasterid Tamsulosin Zentiva
Dosage Form : Caps
Dosage Strength : 0.5/0.4mg
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Switzerland
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Regulatory Info :
Registration Country : Switzerland
Dutasteride; Tamsulosin hydrochloride
Brand Name : Dutasterid Tamsulosin Zentiva
Dosage Form : Caps
Dosage Strength : 0.5/0.4mg
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Switzerland
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Regulatory Info :
Registration Country : Switzerland
Dutasteride; Tamsulosin hydrochloride
Brand Name : Dutasteride Tamsulosin Zentiva
Dosage Form : Caps
Dosage Strength : 0.5/0.4mg
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Switzerland
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Regulatory Info :
Registration Country : Switzerland
Brand Name : Tamsulosin retard Zentiva
Dosage Form : Ret Caps
Dosage Strength : 0.4mg
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Switzerland
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Regulatory Info :
Registration Country : Switzerland
Brand Name : Tamsulosin retard Zentiva
Dosage Form : Ret Caps
Dosage Strength : 0.4mg
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Switzerland
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Regulatory Info :
Registration Country : Switzerland
Brand Name : Tamsulosin retard Zentiva
Dosage Form : Ret Caps
Dosage Strength : 0.4mg
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Switzerland
Regulatory Info :
Registration Country : Italy
Brand Name : TAMSULOSIN THINKS
Dosage Form : Hard Capsules With Modified Release
Dosage Strength : 0.4 mg
Packaging : 20 UNITS 0.4 MG - ORAL USE
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Italy
Regulatory Info :
Registration Country : Italy
Brand Name : TAMSULOSIN THINKS
Dosage Form : Modified Release Hard Capsules
Dosage Strength : 0.4 mg
Packaging : 30 UNITS 0.4 MG - ORAL USE
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Italy
Regulatory Info :
Registration Country : Norway
Tamsulosin Hydrochloride; Solifenacin
Brand Name : Urizia
Dosage Form : Antic-calc tablet Modified Release
Dosage Strength : 6MG; 0.4MG
Packaging : Blister
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Norway
Regulatory Info :
Registration Country : Switzerland
Brand Name : Omix Ocas
Dosage Form : Ret Tablet
Dosage Strength : 0.4mg
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Switzerland
DRUG PRODUCT COMPOSITIONS
Related Excipient Companies
Dosage Form : Clinical Supply
Grade : Oral
Application : Empty Capsules
Excipient Details : ACGCAPS™ GC is specially designed for use in clinical trials and comes in the available sizes: AA, A & B.
Pharmacopoeia Ref : Not Available
Technical Specs : Not Available
Ingredient(s) : Gelatin, Unspecified
Dosage Form : Inhalation
Grade : Inhalation
Application : Empty Capsules
Excipient Details : ACGCAPS™ GI / HI is available in gelatin and cellulose (HPMC) material options and is designed for optimal performance with DPI formulations and various inhalation devices.
Pharmacopoeia Ref : Not Available
Technical Specs : Not Available
Ingredient(s) : Gelatin, Unspecified
Dosage Form : HardGel
Grade : Oral
Application : Empty Capsules
Excipient Details : ACGCAPS™ GL / HL is available in gelatin and cellulose (HPMC) material options and can be used for liquids, semi-liquids, hot-melts and combination fills.
Pharmacopoeia Ref : Not Available
Technical Specs : Not Available
Ingredient(s) : Gelatin, Unspecified
Dosage Form : HardGel
Grade : Oral
Application : Empty Capsules
Excipient Details : ACGCAPS™ GR can fulfill immediate release needs and is available in 15 sizes (from # 000 to # 5).
Pharmacopoeia Ref : Not Available
Technical Specs : Not Available
Ingredient(s) : Gelatin, Unspecified
Dosage Form : Injectable / Parenteral
Grade : Parenteral
Brand Name : Glycerol Multi-Compendial
Application : Parenteral
Excipient Details : A & C's Glycerol multi-compendial is an excipient that meets USP-NF, EP and BP monographs.
Pharmacopoeia Ref : Multi-compendial
Technical Specs : Not Available
Ingredient(s) : Glycerol Excipient
Dosage Form : Injectable / Parenteral
Grade : Parenteral
Application : Parenteral
Excipient Details : A & C's Glycerol is an excipient which meets the USP monograph.
Dosage Form : Gel
Grade : Parenteral, Topical
Brand Name : Polyethylene Glycol 200 N...
Application : Topical
Excipient Details : A & C's Polyethylene Glycol 200 is an excipient which meets the NF monograph.
Pharmacopoeia Ref : NF
Technical Specs : Polyethylene Glycol 200; Polyethylene Glycol 300; Polyethylene Glycol 400; Low Endotoxin
Ingredient(s) : polyethylene glycol
Dosage Form : Cream / Lotion / Ointment
Grade : Topical, Parenteral
Brand Name : Polyethylene Glycol 300 N...
Application : Topical
Excipient Details : A & C's Polyethylene Glycol 300 is an excipient which meets the NF monograph.
Dosage Form : Gel
Grade : Topical, Parenteral
Brand Name : Polyethylene Glycol 400
Application : Topical
Excipient Details : A&C's Polyethylene Glycol 400 USP-NF is a short chain non-ionic surfactant.
Pharmacopoeia Ref : Not Available
Technical Specs : Low Endotoxin
Ingredient(s) : polyethylene glycol
Dosage Form : Tablet
Grade : Topical and Oral
Brand Name : Polyethylene Glycol 400
Application : Controlled & Modified Release
Pharmacopoeia Ref : Not Available
Technical Specs : Not Available
Ingredient(s) : polyethylene glycol
Dosage Form : Capsule
Grade : Oral
Brand Name : Polysorbate 80 Multi-Comp...
Application : Solubilizers
Excipient Details : A & C's Polysorbate 80 multi-compendial is an excipient which meets USP-NF, EP, BP and JP monographs.
Dosage Form : Capsule
Grade : Oral
Brand Name : Polysorbate 80 NF
Application : Solubilizers
Excipient Details : A & C's Polysorbate 80 is an excipient which meets the NF monograph.
Dosage Form : Injectable / Parenteral
Grade : Parenteral
Brand Name : Potassium Chloride
Application : Parenteral
Pharmacopoeia Ref : Not Available
Technical Specs : Not Available
Ingredient(s) : Potassium Chloride Excipient
Dosage Form : Cream / Lotion / Ointment
Grade : Topical and Oral
Application : Topical
Dosage Form : Tablet
Grade : Oral
Dosage Form : Emulsion
Grade : Oral, Ophthalmic
Dosage Form : Tablet
Grade : Oral
Dosage Form : Tablet
Grade : Oral
Excipients by Applications
Global Sales Information
Market Place
Patents & EXCLUSIVITIES
REF. STANDARDS & IMPURITIES
ANALYTICAL
ABOUT THIS PAGE
LOOKING FOR A SUPPLIER?